Share

More Pharmaceutical Industry Articles

  • Cheaper drugs can also mean less choice without savings for patients

    The economics of American healthcare are dictated by the Golden Rule: "He who has the gold makes the rules."

  • White House asks for $30M for CDC's Ebola efforts

    WASHINGTON (AP) — The White House on Friday sent Congress a request for $30 million to pay for the Center for Disease Control and Prevention's efforts to help contain the Ebola outbreak in western Africa. The administration wants the money added to a spending bill to keep government agencies...

  • Pharmacist arrested in tainted steroid case

    BOSTON (AP) — A pharmacist who oversaw the sterile clean rooms at a Massachusetts compounding pharmacy responsible for a deadly meningitis outbreak was arrested Thursday as he was about to board a flight for Hong Kong, federal officials said. Glenn Adam Chin, a former supervisory pharmacist at...

  • FDA OKs Merck drug, 1st in new cancer drug class

    TRENTON, N.J. (AP) — Merck & Co. on Thursday won the first U.S. approval for a new kind of cancer drug with big advantages over chemotherapy and other older cancer treatments. The Food and Drug Administration said it has granted accelerated approval to Merck's Keytruda, for treating melanoma...

  • Highmark sues UPMC over billing for cancer drugs

    PITTSBURGH (AP) — Health insurer Highmark Inc. has sued the University of Pittsburgh Medical Center claiming the hospital network has overbilled it by $300 million for cancer drugs since 2010. Highmark's lawsuit, filed late Wednesday, contends UPMC has been charging for chemotherapy treatments...

  • FDA: Little evidence to support testosterone drugs

    WASHINGTON (AP) — The Food and Drug Administration says there is little evidence that testosterone-boosting drugs taken by millions of American men are beneficial, though the agency is also unconvinced by studies suggesting the hormone carries serious risks. The agency posted its review online...

  • Study: Novel heart failure drug shows big promise

    A new study reports one of the biggest potential advances against heart failure in more than a decade — a first-of-a-kind, experimental drug that lowered the chances of death or hospitalization by about 20 percent. Doctors say the Novartis drug — which doesn't have a name yet — seems like one...

  • Experimental Ebola drug heals all monkeys in study

    An experimental Ebola drug healed all 18 monkeys infected with the deadly virus in a study, boosting hopes that the treatment might help fight the outbreak raging through West Africa — once more of it can be made. The monkeys were given the drug, ZMapp, three to five days after they were...



From the Weekly Standard